Suppr超能文献

泰-萨克斯病(一种罕见的儿科疾病)患者的护理计划

Nursing Care Plan for Patients with Tay-Sachs-A Rare Paediatric Disease.

作者信息

Cortés-Martín Jonathan, Piqueras-Sola Beatriz, Sánchez-García Juan Carlos, Reinoso-Cobo Andrés, Ramos-Petersen Laura, Díaz-Rodríguez Lourdes, Rodríguez-Blanque Raquel

机构信息

Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain.

Hospital University Virgen de las Nieves, 18014 Granada, Spain.

出版信息

J Pers Med. 2023 Aug 1;13(8):1222. doi: 10.3390/jpm13081222.

Abstract

Tay-Sachs disease is classified as a rare paediatric disease of metabolic origin. It is an autosomal recessive inherited disease. The gene responsible for the disease is known as HEXA, and it is located on chromosome 15(15q23). There is currently no effective treatment for Tay-Sachs disease; hence, it is an incurable disease in which patients do not live for more than five years, meaning that nursing care takes on greater importance to maintain quality of life. The main objective of this work is to develop a specific standard nursing care plan by applying an inductive research method supported by nursing methodology using the NANDA-NIC-NOC taxonomy and validated by the Delphi method. This care plan will improve the knowledge of health professionals on this topic and support future studies on the disease. Following its implementation, the care plan proposed in this study aims to increase the quality of life of patients diagnosed with this disease.

摘要

泰-萨克斯病被归类为一种罕见的代谢性儿科疾病。它是一种常染色体隐性遗传病。导致该疾病的基因名为HEXA,位于15号染色体(15q23)上。目前尚无治疗泰-萨克斯病的有效方法;因此,它是一种不治之症,患者存活时间不超过五年,这意味着护理对于维持生活质量更为重要。本研究的主要目的是通过采用以护理方法学为支撑的归纳研究方法,运用NANDA-NIC-NOC分类法并经德尔菲法验证,制定一份特定的标准护理计划。该护理计划将提高医护人员对这一主题的认识,并为该疾病的未来研究提供支持。本研究提出的护理计划在实施后旨在提高被诊断患有这种疾病的患者的生活质量。

相似文献

1
Nursing Care Plan for Patients with Tay-Sachs-A Rare Paediatric Disease.
J Pers Med. 2023 Aug 1;13(8):1222. doi: 10.3390/jpm13081222.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
New Approaches to Tay-Sachs Disease Therapy.
Front Physiol. 2018 Nov 20;9:1663. doi: 10.3389/fphys.2018.01663. eCollection 2018.
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
5
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
7
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.
Orphanet J Rare Dis. 2018 Sep 17;13(1):152. doi: 10.1186/s13023-018-0886-3.
8
Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.
Klin Padiatr. 2021 Sep;233(5):226-230. doi: 10.1055/a-1371-1561. Epub 2021 Apr 8.
9
Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.
PLoS One. 2023 Mar 16;18(3):e0280650. doi: 10.1371/journal.pone.0280650. eCollection 2023.

引用本文的文献

1
Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders.
Int J Mol Sci. 2024 Oct 11;25(20):10949. doi: 10.3390/ijms252010949.

本文引用的文献

1
Late-Onset Tay-Sachs Disease - expanding the clinical phenotype.
Tremor Other Hyperkinet Mov (N Y). 2023 Jan 31;13:4. doi: 10.5334/tohm.750. eCollection 2023.
2
Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.
Tremor Other Hyperkinet Mov (N Y). 2022 Dec 27;12:34. doi: 10.5334/tohm.726. eCollection 2022.
3
GM1-gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat.
Am J Med Genet A. 2023 Feb;191(2):408-423. doi: 10.1002/ajmg.a.63038. Epub 2022 Dec 21.
4
Clinical and Laboratory Profile of Gangliosidosis from Southern Part of India.
J Pediatr Genet. 2020 Oct 19;11(1):34-41. doi: 10.1055/s-0040-1718726. eCollection 2022 Mar.
5
AAV gene therapy for Tay-Sachs disease.
Nat Med. 2022 Feb;28(2):251-259. doi: 10.1038/s41591-021-01664-4. Epub 2022 Feb 10.
6
Rare coexistence of Tay-Sachs disease, coarctation of the aorta and grade V vesicoureteral reflux.
Arch Argent Pediatr. 2022 Feb;120(1):e25-e28. doi: 10.5546/aap.2022.eng.e25. Epub 2022 Jan 1.
7
[Rehabilitation in Tay-Sachs disease: A case report].
Rehabilitacion (Madr). 2022 Apr-Jun;56(2):164-167. doi: 10.1016/j.rh.2020.10.010. Epub 2021 Apr 6.
8
Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.
Klin Padiatr. 2021 Sep;233(5):226-230. doi: 10.1055/a-1371-1561. Epub 2021 Apr 8.
9
Two patients from Turkey with a novel variant in the gene and review of the literature.
J Pediatr Endocrinol Metab. 2021 Apr 6;34(6):805-812. doi: 10.1515/jpem-2020-0655. Print 2021 Jun 25.
10
Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy.
Mol Genet Genomic Med. 2021 Jun;9(6):e1677. doi: 10.1002/mgg3.1677. Epub 2021 Apr 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验